Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 21
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05558982 | BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT04382170 | Dexmedetomidine Sublingual Film for the Management of Agitation in Delirium: Safety and Preliminary Efficacy | ||
| NCT06335407 | Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study | ||
| NCT05025605 | Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder | ||
| NCT06093451 | Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder | ||
| NCT05313386 | Study of BXCL501 In Agitation Associated With Delirium in ICU Patients | ||
| NCT03910660 | A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. | ||
| NCT05271552 | Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II) | ||
| NCT06041646 | Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder | ||
| NCT04827056 | Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study | ||
| NCT04268303 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia | ||
| NCT05665088 | Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) | ||
| NCT04010305 | Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia | ||
| NCT04276883 | Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder | ||
| NCT04123574 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | ||
| NCT05658510 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) | ||
| NCT04470050 | Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal | ||
| NCT05276830 | An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia | ||
| NCT04251910 | Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia | ||
| NCT05712707 | Sublingual Dexmedetomidine for Treating Opioid Withdrawal | ||
| NCT07116694 | Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder |
